Title:
FUSED RING COMPOUND USED AS WEE-1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2022/171126
Kind Code:
A1
Abstract:
Disclosed in the present invention is a fused ring compound used as a Wee-1 inhibitor. Specifically, the present invention relates to a compound represented by general formula (1) and a preparation method therefor, and a use of the compound of general formula (1) and isomers, crystal forms, pharmaceutically acceptable salts, hydrates, or solvates thereof as Wee-1 inhibitors in the preparation of an antitumor drug.
Inventors:
XIE YULI (CN)
FAN HOUXING (CN)
QIAN LIHUI (CN)
FAN HOUXING (CN)
QIAN LIHUI (CN)
Application Number:
PCT/CN2022/075655
Publication Date:
August 18, 2022
Filing Date:
February 09, 2022
Export Citation:
Assignee:
WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61P35/00; C07D471/04
Domestic Patent References:
| WO2018011569A1 | 2018-01-18 | |||
| WO2019037678A1 | 2019-02-28 | |||
| WO2019074979A1 | 2019-04-18 |
Foreign References:
| EP2213673A1 | 2010-08-04 | |||
| CN111902413A | 2020-11-06 | |||
| CN101432284A | 2009-05-13 | |||
| CN111718348A | 2020-09-29 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: FASTENING DEVICE AND TIE CORD WINDING/UNWINDING METHOD
Next Patent: REDUCING START LATENCY OF SERVERLESS MICROSERVICES
Next Patent: REDUCING START LATENCY OF SERVERLESS MICROSERVICES